Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas

MLA

Seelemeyer, F., et al. “Evaluation of MiRNA-371a-3p (MiR371a) Assay to Predict Final Pathohistology in Patients Undergoing Primary Nerve-Sparing Retroperitoneal Lymphadenectomy (NsRPLND) for Stage IIA/B Seminomas and Non-Seminomas.” 68. Kongress Der Nordrhein-Westfälischen Gesellschaft Für Urologie; 20230330-20230331; Essen; DOCP 1.10 /20230328/, 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1393502110&authtype=sso&custid=ns315887.

APA

Seelemeyer, F., Pfister, D., Paffenholz, P., Stammel, C., Pappesch, R., Merkelbach-Bruse, S., & Heidenreich, A. (2023). Evaluation of miRNA-371a-3p (miR371a) assay to predict final pathohistology in patients undergoing primary nerve-sparing retroperitoneal lymphadenectomy (nsRPLND) for stage IIA/B seminomas and non-seminomas. 68. Kongress Der Nordrhein-Westfälischen Gesellschaft Für Urologie; 20230330-20230331; Essen; DOCP 1.10 /20230328/.

Chicago

Seelemeyer, F, D Pfister, P Paffenholz, C Stammel, R Pappesch, S Merkelbach-Bruse, and A Heidenreich. 2023. “Evaluation of MiRNA-371a-3p (MiR371a) Assay to Predict Final Pathohistology in Patients Undergoing Primary Nerve-Sparing Retroperitoneal Lymphadenectomy (NsRPLND) for Stage IIA/B Seminomas and Non-Seminomas.” 68. Kongress Der Nordrhein-Westfälischen Gesellschaft Für Urologie; 20230330-20230331; Essen; DOCP 1.10 /20230328/. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1393502110&authtype=sso&custid=ns315887.